Study for the Medical FIDSAP v2 Test. Sharpen your skills with flashcards and multiple-choice questions, complete with hints and explanations. Prepare effectively for your upcoming test!

Multiple Choice

What is first-line antibiotic for uncomplicated cystitis in nonpregnant women?

Nitrofurantoin is chosen because it targets the infection right where it lives: the urinary tract. It concentrates in the bladder and acts mainly on the usual culprits of uncomplicated cystitis, like E. coli and Staph saprophyticus, while delivering minimal systemic exposure. This focused activity provides effective symptom relief and high cure rates for a simple lower UTI without broad-spectrum effects that can drive resistance. The typical regimen is short and well tolerated, which helps adherence and reduces side effects. Nitrofurantoin’s profile makes it preferred over broader or less urine-focused antibiotics. Amoxicillin is generally avoided because many urinary pathogens are resistant to it. Fluoroquinolones are potent but are now reserved for cases where alternatives fail due to rising resistance and potential adverse effects, and because of their broader systemic exposure. Azithromycin does not achieve reliable concentrations in urine for the organisms that commonly cause cystitis, so it isn’t suitable as a first-line option for this scenario.

Nitrofurantoin is chosen because it targets the infection right where it lives: the urinary tract. It concentrates in the bladder and acts mainly on the usual culprits of uncomplicated cystitis, like E. coli and Staph saprophyticus, while delivering minimal systemic exposure. This focused activity provides effective symptom relief and high cure rates for a simple lower UTI without broad-spectrum effects that can drive resistance.

The typical regimen is short and well tolerated, which helps adherence and reduces side effects. Nitrofurantoin’s profile makes it preferred over broader or less urine-focused antibiotics.

Amoxicillin is generally avoided because many urinary pathogens are resistant to it. Fluoroquinolones are potent but are now reserved for cases where alternatives fail due to rising resistance and potential adverse effects, and because of their broader systemic exposure. Azithromycin does not achieve reliable concentrations in urine for the organisms that commonly cause cystitis, so it isn’t suitable as a first-line option for this scenario.